Check out your Company Bowl for anonymous work chats.
SOPHiA GENETICS proudly stepped up as a founding member of #CancerX in Washington, DC. Alongside over 125 other organizations, we participated in the inaugural meeting, opening a new chapter in the fight against cancer. The White House is spearheading ambitious plans to fight against cancer. Among 17 bold initiatives under the Cancer Moonshot program, CancerX stands out, being the only initiative leveraging the full potential of #digitalinnovation. SOPHiA GENETICS is honored to contribute to turning this vision into reality. 📍 Follow us for updates on this exciting path we’re paving! https://lnkd.in/dwWJZ7qm
Join us at the NASDAQ Headquarters for the "AI-Driven Precision Oncology Summit" on September 26, 2023, where we will unveil the potential of data-driven innovation.
SOPHiA GENETICS is pleased to announce its Q2 2023 financial results. Highlights from this quarterly report include: - 29% revenue growth YoY on a reported basis - Record platform analysis volume, up 27% YoY* - Continued customer traction, including Tulane University School of Medicine based in the U.S., just announced today - Strong gross margins at 67% - Continued financial discipline resulting in meaningful expense reductions and improved cash flow 📌 Read more in our full earnings press release here:
"The perks of my job are the constant challenges; we are always pushed to do things better and to perform at our best. Here at SOPHiA GENETICS, team spirit is the key! Everybody wants to do their best and bring you the best of their knowledge to make things better. I’ve always really enjoyed sharing my experience, so this is important for me. Software is never just software, behind it are the users. That’s why a spirit of wisdom sharing is so important for us." - Fabien Nisol
"We have a huge international footprint with people from North America, South America, Asia - all over the world! – and this creates a very inspiring dynamic in the company. Although we are very diverse in the way we think or act, everyone shares the same vision: to help support the clinical fields with our technologies to be as global as we are." - Thierry Colin, VP Radiomics
"We have a huge opportunity to help improve patients’ lives. We have the technology to help change their destinies and this is something that is more than an opportunity, it’s a mission that we have to fulfil." - Paola Castelli
